Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Haemostatic, fibrinolytic and inflammatory profiles in West Highland white terriers with canine idiopathic pulmonary fibrosis and controls.

Roels E, Bauer N, Lecut C, Moritz A, Gothot A, Clercx C.

BMC Vet Res. 2019 Oct 29;15(1):379. doi: 10.1186/s12917-019-2134-z.

2.

P2X1 ion channel deficiency causes massive bleeding in inflamed intestine and increases thrombosis.

Wéra O, Lecut C, Servais L, Hego A, Delierneux C, Jiang Z, Keutgens A, Evans RJ, Delvenne P, Lancellotti P, Oury C.

J Thromb Haemost. 2019 Aug 26. doi: 10.1111/jth.14620. [Epub ahead of print]

PMID:
31448510
3.

Platelet-rich plasma (PRP) and tendon healing: comparison between fresh and frozen-thawed PRP.

Kaux JF, Libertiaux V, Dupont L, Colige A, Denoël V, Lecut C, Hego A, Gustin M, Duwez L, Oury C, Gothot A, Greimers L, Drion P.

Platelets. 2019 Mar 27:1-5. doi: 10.1080/09537104.2019.1595563. [Epub ahead of print]

PMID:
30915890
4.

IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes.

Momozawa Y, Dmitrieva J, Théâtre E, Deffontaine V, Rahmouni S, Charloteaux B, Crins F, Docampo E, Elansary M, Gori AS, Lecut C, Mariman R, Mni M, Oury C, Altukhov I, Alexeev D, Aulchenko Y, Amininejad L, Bouma G, Hoentjen F, Löwenberg M, Oldenburg B, Pierik MJ, Vander Meulen-de Jong AE, Janneke van der Woude C, Visschedijk MC; International IBD Genetics Consortium, Lathrop M, Hugot JP, Weersma RK, De Vos M, Franchimont D, Vermeire S, Kubo M, Louis E, Georges M.

Nat Commun. 2018 Jun 21;9(1):2427. doi: 10.1038/s41467-018-04365-8.

5.

Effects of Allogeneic Platelet-Rich Plasma (PRP) on the Healing Process of Sectioned Achilles Tendons of Rats: A Methodological Description.

Greimers L, Drion PV, Colige A, Libertiaux V, Denoël V, Lecut C, Gothot A, Kaux JF.

J Vis Exp. 2018 Mar 19;(133). doi: 10.3791/55759.

PMID:
29608156
6.

Soluble GPVI is elevated in injured patients: shedding is mediated by fibrin activation of GPVI.

Montague SJ, Delierneux C, Lecut C, Layios N, Dinsdale RJ, Lee CS, Poulter NS, Andrews RK, Hampson P, Wearn CM, Maes N, Bishop J, Bamford A, Gardiner C, Lee WM, Iqbal T, Moiemen N, Watson SP, Oury C, Harrison P, Gardiner EE.

Blood Adv. 2018 Feb 13;2(3):240-251. doi: 10.1182/bloodadvances.2017011171.

7.

Sepsis prediction in critically ill patients by platelet activation markers on ICU admission: a prospective pilot study.

Layios N, Delierneux C, Hego A, Huart J, Gosset C, Lecut C, Maes N, Geurts P, Joly A, Lancellotti P, Albert A, Damas P, Gothot A, Oury C.

Intensive Care Med Exp. 2017 Dec;5(1):32. doi: 10.1186/s40635-017-0145-2. Epub 2017 Jul 12.

8.

Targeting of C-type lectin-like receptor 2 or P2Y12 for the prevention of platelet activation by immunotherapeutic CpG oligodeoxynucleotides.

Delierneux C, Donis N, Servais L, Wéra O, Lecut C, Vandereyken M, Musumeci L, Rahmouni S, Schneider J, Eble JA, Lancellotti P, Oury C.

J Thromb Haemost. 2017 May;15(5):983-997. doi: 10.1111/jth.13669. Epub 2017 Apr 13.

9.

Eccentric Training for Tendon Healing After Acute Lesion: A Rat Model.

Kaux JF, Libertiaux V, Leprince P, Fillet M, Denoel V, Wyss C, Lecut C, Gothot A, Le Goff C, Croisier JL, Crielaard JM, Drion P.

Am J Sports Med. 2017 May;45(6):1440-1446. doi: 10.1177/0363546517689872. Epub 2017 Mar 14.

PMID:
28291948
10.

Efficacy of the RemoweLL cardiotomy reservoir for fat and leucocyte removal from shed mediastinal blood: a randomized controlled trial.

Lagny MG, Gothot A, Hans GA, Koch JN, Blaffart F, Hella D, Donneau AF, Roediger L, Lecut C, Pincemaïl J, Cheramy-Bien JP, Defraigne JO.

Perfusion. 2016 Oct;31(7):544-51. doi: 10.1177/0267659116649427. Epub 2016 May 13.

PMID:
27178989
11.

Reflections about the optimisation of the treatment of tendinopathies with PRP.

Kaux JF, Bouvard M, Lecut C, Oury C, Gothot A, Sanchez M, Crielaard JM.

Muscles Ligaments Tendons J. 2015 Mar 27;5(1):1-4. eCollection 2015 Jan-Mar.

12.

[Is there a place for thrombin generation assay in routine clinical laboratory?].

Lecut C, Peters P, Massion PB, Gothot A.

Ann Biol Clin (Paris). 2015 Mar-Apr;73(2):137-49. doi: 10.1684/abc.2014.1018. Review. French.

13.

Purinergic control of inflammation and thrombosis: Role of P2X1 receptors.

Oury C, Lecut C, Hego A, Wéra O, Delierneux C.

Comput Struct Biotechnol J. 2014 Nov 28;13:106-10. doi: 10.1016/j.csbj.2014.11.008. eCollection 2015. Review.

14.

Dual-specificity phosphatase 3 deficiency or inhibition limits platelet activation and arterial thrombosis.

Musumeci L, Kuijpers MJ, Gilio K, Hego A, Théâtre E, Maurissen L, Vandereyken M, Diogo CV, Lecut C, Guilmain W, Bobkova EV, Eble JA, Dahl R, Drion P, Rascon J, Mostofi Y, Yuan H, Sergienko E, Chung TD, Thiry M, Senis Y, Moutschen M, Mustelin T, Lancellotti P, Heemskerk JW, Tautz L, Oury C, Rahmouni S.

Circulation. 2015 Feb 17;131(7):656-68. doi: 10.1161/CIRCULATIONAHA.114.010186. Epub 2014 Dec 17.

15.

P2X1 expressed on polymorphonuclear neutrophils and platelets is required for thrombosis in mice.

Darbousset R, Delierneux C, Mezouar S, Hego A, Lecut C, Guillaumat I, Riederer MA, Evans RJ, Dignat-George F, Panicot-Dubois L, Oury C, Dubois C.

Blood. 2014 Oct 16;124(16):2575-85. doi: 10.1182/blood-2014-04-571679. Epub 2014 Aug 22.

16.

The Ca(2+) /calmodulin-dependent kinase kinase β-AMP-activated protein kinase-α1 pathway regulates phosphorylation of cytoskeletal targets in thrombin-stimulated human platelets.

Onselaer MB, Oury C, Hunter RW, Eeckhoudt S, Barile N, Lecut C, Morel N, Viollet B, Jacquet LM, Bertrand L, Sakamoto K, Vanoverschelde JL, Beauloye C, Horman S.

J Thromb Haemost. 2014 Jun;12(6):973-86. doi: 10.1111/jth.12568.

17.

Connection between cardiac vascular permeability, myocardial edema, and inflammation during sepsis: role of the α1AMP-activated protein kinase isoform.

Castanares-Zapatero D, Bouleti C, Sommereyns C, Gerber B, Lecut C, Mathivet T, Horckmans M, Communi D, Foretz M, Vanoverschelde JL, Germain S, Bertrand L, Laterre PF, Oury C, Viollet B, Horman S, Beauloye C.

Crit Care Med. 2013 Dec;41(12):e411-22. doi: 10.1097/CCM.0b013e31829866dc.

PMID:
23963133
18.

Overexpression of CD39 in mouse airways promotes bacteria-induced inflammation.

Théâtre E, Frederix K, Guilmain W, Delierneux C, Lecut C, Bettendorff L, Bours V, Oury C.

J Immunol. 2012 Aug 15;189(4):1966-74. doi: 10.4049/jimmunol.1102600. Epub 2012 Jul 16.

19.

ATP-gated P2X1 ion channels protect against endotoxemia by dampening neutrophil activation.

Lecut C, Faccinetto C, Delierneux C, van Oerle R, Spronk HM, Evans RJ, El Benna J, Bours V, Oury C.

J Thromb Haemost. 2012 Mar;10(3):453-65. doi: 10.1111/j.1538-7836.2011.04606.x.

20.

P2X1 ion channels promote neutrophil chemotaxis through Rho kinase activation.

Lecut C, Frederix K, Johnson DM, Deroanne C, Thiry M, Faccinetto C, Marée R, Evans RJ, Volders PG, Bours V, Oury C.

J Immunol. 2009 Aug 15;183(4):2801-9. doi: 10.4049/jimmunol.0804007. Epub 2009 Jul 27.

21.
22.

Contribution of platelet glycoprotein VI to the thrombogenic effect of collagens in fibrous atherosclerotic lesions.

Cosemans JM, Kuijpers MJ, Lecut C, Loubele ST, Heeneman S, Jandrot-Perrus M, Heemskerk JW.

Atherosclerosis. 2005 Jul;181(1):19-27. Epub 2005 Feb 12.

PMID:
15939050
23.

Identification of residues within human glycoprotein VI involved in the binding to collagen: evidence for the existence of distinct binding sites.

Lecut C, Arocas V, Ulrichts H, Elbaz A, Villeval JL, Lacapère JJ, Deckmyn H, Jandrot-Perrus M.

J Biol Chem. 2004 Dec 10;279(50):52293-9. Epub 2004 Oct 4.

24.

Principal role of glycoprotein VI in alpha2beta1 and alphaIIbbeta3 activation during collagen-induced thrombus formation.

Lecut C, Schoolmeester A, Kuijpers MJ, Broers JL, van Zandvoort MA, Vanhoorelbeke K, Deckmyn H, Jandrot-Perrus M, Heemskerk JW.

Arterioscler Thromb Vasc Biol. 2004 Sep;24(9):1727-33. Epub 2004 Jul 1.

25.

Severe deficiency of glycoprotein VI in a patient with gray platelet syndrome.

Nurden P, Jandrot-Perrus M, Combrié R, Winckler J, Arocas V, Lecut C, Pasquet JM, Kunicki TJ, Nurden AT.

Blood. 2004 Jul 1;104(1):107-14. Epub 2004 Mar 9.

PMID:
15010364
26.

Human platelet glycoprotein VI function is antagonized by monoclonal antibody-derived Fab fragments.

Lecut C, Feeney LA, Kingsbury G, Hopkins J, Lanza F, Gachet C, Villeval JL, Jandrot-Perrus M.

J Thromb Haemost. 2003 Dec;1(12):2653-62.

27.

Expression and function of the collagen receptor GPVI during megakaryocyte maturation.

Lagrue-Lak-Hal AH, Debili N, Kingbury G, Lecut C, Le Couedic JP, Villeval JL, Jandrot-Perrus M, Vainchenker W.

J Biol Chem. 2001 May 4;276(18):15316-25. Epub 2001 Jan 16.

28.

Basic residues of human group IIA phospholipase A2 are important for binding to factor Xa and prothrombinase inhibition comparison with other mammalian secreted phospholipases A2.

Mounier CM, Luchetta P, Lecut C, Koduri RS, Faure G, Lambeau G, Valentin E, Singer A, Ghomashchi F, Béguin S, Gelb MH, Bon C.

Eur J Biochem. 2000 Aug;267(16):4960-9.

Supplemental Content

Support Center